Skip to main content
OpenTrials
Completed

NCT Number: NCT04969380

SofWave Treatment to Lift Lax Tissue in the Submental and Neck Zones and to Lift the Eyebrow

Open-label, non-randomized, prospective, multi-center, self-controlled clinical study with masked evaluation.

Completed

Looking for future studies?

Notify Me

Key information

Age range

35 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of California

Irvine, California, 92697, United States

About this study

Eligible patients will receive 2 face and neck treatments (4-6 weeks ± 2 weeks apart) using the SofWave System. Each investigational site would treat the full face and submental zones including 1. The forehead and temples (left and right including the peri orbital zone) to lift the eyebrows 2. The cheeks (left and right including perioral zone and nasolabial folds) 3. Submental and sides of the neck (left and right) to lift lax skin.

All patients will return to the clinic for two follow up visits: 1. 7 days (FU1) post the first treatment (Tx.1). 2. 3 months ± 2 weeks post last treatment (FU2).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy female and male subjects between the ages 35-80.
  • Non-Smoker.
  • Fitzpatrick skin type I-VI.
  • Desire to lift lax skin in the neck and submental and/or to lift the brows.
  • Able and willing to comply with all visit, treatment and evaluation schedules and requirements.
  • Able to understand and provide written Informed Consent
  • Women of child-bearing age are required to be using a reliable method of birth control at least 3 months prior to study enrollment.

Exclusion criteria

  • Pregnant or planning to become pregnant, having given birth less than 3 months ago, and/or breast feeding.
  • Presence of any active systemic or local infections.
  • Presence of active local skin disease that may alter wound healing.
  • Severe solar elastosis.
  • History of smoking in past 10 years.
  • History of chronic drug or alcohol abuse.
  • Excessive subcutaneous fat on the cheeks.
  • Significant scarring in the area to be treated.
  • Severe or cystic facial acne, acutance uses during past 6 months.
  • Presence of a metal stent or implant in the facial area (dental implants and/or braces are not excluded).
  • Inability to understand the protocol or to give informed consent.
  • History of cosmetic treatments in the facial area to be treated, including facial skin-tightening procedure within the 6 months ; injectable (Botox or fillers) of any type within the 6 months; ablative or non-ablative resurfacing/rejuvenation laser treatment or light treatment within the past 6 months, dermabrasion or deep facial peels within the past 12 months; facelift, blepharoplasty, or brow lift (including contour threads) within the past 12 months.
  • Taking Isotretinoin or other oral retinoid within the past 6 months; taking anti-platelet or anti-coagulant within the past 2 weeks.
  • As per the investigator's discretion, any physical or mental condition which might make it unsafe for the subject to participate in this study.

Treatment and study plan

SofWave

Device

The Sofwave System, comprised of an applicator and a console, generates high intensity, non-focused ultrasonic energy which can be delivered percutaneously to tissues.

Primary outcomes

  1. Change in lift of lax tissue

    Time frame: 3 and 6 months post last treatment

    As assessed by independent masked evaluators. Quantitative image analysis to objectively measure change in lift of the eyebrow and submental and neck lax tissue would be conducted by comparing baseline images to those taken at each visit post FU1 (Pre Tx.2, FU2)

Sponsors and collaborators

Lead sponsor

Sofwave Medical LTD

Industry

Registry information

Official study title

Safety and Efficacy of Sofacia Treatment to Improve Facial Lines and Wrinkles, to Lift Lax Tissue in the Submental and Neck Zones and to Lift the Eyebrow

Important dates

Study start
2020
Primary completion
2023
Study completion
2023
First posted
Jul 20, 2021
Registry last updated
Nov 18, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.